Predicting post-kidney transplant dementia/Alzheimer's Disease risk in older patients
- Institution
- NEW YORK UNIVERSITY SCHOOL OF MEDICINE, NY
- Principal investigator
- Jane J Long
- Funding
- $99K
- Duration
- 2023–2026
Moonbase score
Still being scored
Abstract
PROJECT SUMMARY/ABSTRACT Kidney transplantation (KT) is increasing for older adults (≥50) with ESRD. In 2021, older adults received roughly 60% of all KTs and are at increased risk of dementia/Alzheimer’s disease (AD). KT recipients who develop dementia/AD post-transplant have a 2.4-fold increased risk of mortality and a 1.5-fold increased risk of graft loss. Of older KT recipients who are diagnosed with dementia/AD, 88.6% die within 10 years. These deaths may be due to inability to perform self-care, inadequate nutrition, or medication non-adherence. Despite these risks, predicting who will develop post KT dementia/AD is not part of pre-KT evaluation. Furthermore, factors routinely measured at pre-KT evaluation (age, sex, comorbidities, etc.) have only moderate predictive power for post-KT dementia/AD. Predicting post-KT dementia/AD risk can help identify older candidates who would benefit from interventions such as cognitive prehabilitation or post-KT surveillance. Predicting post-KT dementia/AD risk at transplant evaluation provides enough time to intervene prior to KT. To design a geriatric-specific model that can predict post-KT dementia/AD risk utilizing machine learning, we will leverage an ongoing NIA-funded R01 prospective longitudinal cohort study of frailty among older KT candidates to accomplish the following aims: (1) To identify dementia/AD cases and possible subtypes among KT recipients and quantify the cumulative incidence of AD/dementia in KT recipients in this ongoing cohort study; (2) To identify clinical, geriatric, and ESRD-specific risk factors that are associated with post-KT dementia/AD; and (3) To design a model with the aid of machine learning that successfully predicts the risk of post-KT dementia/AD in older patients undergoing KT evaluation. Our group’s expertise in frailty and dementia/AD and access to the ongoing Frailty Assessment in Renal Disease (FAIR) cohort, along with Dr. Long’s training interests in machine learning and regression, provide a unique opportunity to build prediction models that could identify older candidates at highest risk of post-KT dementia/AD. We hypothesize that a risk prediction tool that incorporates traditional clinical, geriatric, and ESRD-specific risk factors that are commonly measured at KT evaluation, will improve post-KT dementia/AD risk prediction. If the proposed aims are achieved, we will improve our ability to identify older patients at increased risk of developing post-KT dementia/AD, who will need additional interventions to improve post-KT outcomes.
LOADING MOONBASE SCORE
Questions for NEW YORK UNIVERSITY SCHOOL OF MEDICINE
Answered by the team behind this research.
No questions yet. Sign in to ask the first one
Related grants
Same institution, same topic, scored first.
- NIH · New York University School of Medicine68
EPITRANSCRIPTOMIC REGULATION OF CYTOMEGALOVIRUS INFECTION
Daniel Pearce Depledge · $529K · 2020–2026
- NIH · New York University School of Medicine67
RELAXaHEAD: A Behavioral Approach to Remote Migraine Management in Primary Care
Mia Minen · $2.3M · 2022–2028
- NIH · New York University School of Medicine65
Multinuclear MRI to Assess Joint Homeostasis after Knee Injury
Guillaume Madelin · $661K · 2022–2027